Wednesday, October 28, 2026
Data from SEC filings, checked daily
Public filings, plainly told
Insider tradingForm 4

Aktis Oncology, Inc. (AKTS) Insider Trading

1 open-market trades reported since Sep 24, 2026: 0 purchases worth $0 and 1 sales worth $259K.

By insider

InsiderRoleBuysBoughtSellsSoldLatest
Akos CzibereChief Medical Officer0$01$259KSep 24, 2026
ADVERTISEMENT
728 × 90 ad slot320 × 100 ad slot

All trades

AKTS insider trades
FiledTradedInsiderRoleTypeSharesPrice ($)ValueHolding3 mo. afterFiling
Sep 24Sep 23Akos CzibereChief Medical OfficerChief Medical Officer▼ SELL10b5-112,50020.69$259KAll soldForm 4 ↗
Source: SEC Form 4 filings, retrieved Oct 28, 2026. How we read filings